Physician profile

Ricky Dwayne Latham

Cardiovascular Disease · Idaho Falls, ID

NPI 1477553139

$2,177.19

in general payments reported to CMS, 2019-2025

25 companies · $292 in 2025

The $292 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$674.36

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novartis Pharmaceuticals Corporation $497.92 2020-2024
Medtronic, INC. $348.55 2021-2025 Cobalt Dr Mri Surescan, Adapta, Resolute Onyx
Medtronic Vascular, INC. $290.66 2019-2020
Abbott Laboratories $132.95 2020-2025 Jot Dx
Janssen Pharmaceuticals, INC $126.86 2019-2022
E.R. Squibb & Sons, L.L.C. $118.27 2019-2025 Eliquis
Actelion Pharmaceuticals US, INC. $116.85 2019-2024 Uptravi
Boston Scientific Corporation $80.06 2022-2025 Watchman Flx
Philips North America LLC $55.31 2024-2025 (Ck4) Mcot, Dose Professional Services, Mcot
Siemens Medical Solutions USA, INC. $48.88 2025 Artis Icono Floor, Acuson Origin Diagnostic Ultrasound System
Merck Sharp & Dohme LLC $48.82 2021-2025 Verquvo, Capvaxive
Amgen INC. $42.01 2019-2022
Cvrx, INC. $34.63 2021-2022
Pfizer INC. $31.55 2019-2022
Kiniksa Pharmaceuticals, LTD. $29.59 2023 Arcalyst
Show all 25 companies
CompanyGeneral paymentsYearsTop products
Inspire Medical Systems, INC. $29.56 2023 Inspire
Nestle Healthcare Nutrition INC. $21.15 2022
Edwards Lifesciences Corporation $21.00 2023 Edwards Sapien 3 Transcatheter Heart Valve (Thv)
Zoll Medical Corporation $20.03 2019
Sanofi-Aventis U.S. LLC $18.18 2019
Viatris Specialty LLC $14.28 2025 Yupelri
Celgene Corporation $13.43 2023 Zeposia
Lilly USA, LLC $12.80 2023 Mounjaro
Mylan Specialty L.P. $12.22 2021
Biohaven Pharmaceuticals, INC. $11.63 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ricky Dwayne Latham

$2,177.19

in general payments reported 2019-2025

Years
2019-2025
Top company
Novartis Pharmaceuticals Corporation
Context
The $292 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/157563/ricky-dwayne-latham

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.